About the Journal

Infinity Journal of Medicine and Innovation (IJMI) is an open-access, peer-reviewed journal dedicated to publishing cutting-edge research, reviews, and clinical studies in the field of medicine and healthcare innovation. This journal is tending to bridge the gap between scientific advancements and clinical applications by promoting interdisciplinary research and novel medical approaches.

Publisher Information

Published by: Medical technician society
Address: Al-Shomali District, Babylon Province, Iraq
Email: info@journalscientific-journal.com
Phone: +964 781 730 7280

The Infinity Journal of Medicine and Innovation is independently published and managed by a dedicated academic team, aiming to promote scientific advancement and knowledge dissemination.

Focus and Scope

The Infinity Journal of Medicine and Innovation (IJMI) is a peer-reviewed, open-access journal dedicated to publishing high-quality research that advances the frontiers of medical science and innovation. The journal provides a multidisciplinary platform for the dissemination of original articles, reviews, and case studies that explore transformative developments in the healthcare and biomedical fields.

IJMI welcomes submissions across a broad spectrum of topics, including but not limited to:

  • Medical innovations and emerging technologies

  • Biomedical research and translational medicine

  • Regenerative medicine and tissue engineering

  • Artificial intelligence (AI) and digital health applications

  • Precision medicine and personalized healthcare

  • Drug discovery, targeted therapies, and nanomedicine

  • Epidemiology, public health, and global health challenges

  • Ethical, legal, and regulatory aspects of medical innovation

The journal seeks contributions from academic researchers, clinicians, policy makers, and industry experts who are engaged in shaping the future of healthcare through innovative approaches and scientific excellence.

Open Access Policy

Infinity Journal of Medicine and Innovation (IJMI) is an open access journal, which means that all content is freely available to users without any subscription or payment. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author, in accordance with the Budapest Open Access Initiative (BOAI).

The journal operates under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license, authors retain copyright and grant the journal the right of first publication, while also allowing others to share and adapt the work, provided that appropriate credit is given to the original authors and the source.

Key Principles:

  • Immediate and free access to all published content.

  • No article processing charges (APCs) or submission fees.

  • Authors retain full copyright of their work.

  • Readers may reuse content under the terms of the CC BY 4.0 license, which supports the widest possible dissemination and reuse.

IJMI is committed to the principle that making research freely available to the public supports a greater global exchange of knowledge and accelerates scientific advancement, especially in low- and middle-income countries.

Copyright Notice

Authors retain the copyright of their published articles under a Creative Commons Attribution License (CC BY), allowing unrestricted use, distribution, and reproduction in any medium, provided proper credit is given to the original work.

Peer Review Process

All manuscripts submitted to Infinity Journal of Medicine and Innovation (IJMI) undergo a rigorous, double-blind peer review process to ensure the highest standards of academic quality and integrity.

1. Initial Screening

Upon submission, each manuscript is first evaluated by the Editor-in-Chief or a designated editorial board member to assess its compliance with the journal's scope, formatting requirements, and ethical standards. Manuscripts that do not meet the basic criteria may be desk-rejected without external review.

2. Double-Blind Peer Review

If deemed suitable, the manuscript is then sent to at least two independent expert reviewers in the relevant field. Both the reviewers and the authors remain anonymous throughout the review process. Reviewers are selected based on their expertise, academic credentials, and previous experience in the subject area.

Review Criteria

Reviewers are asked to evaluate the manuscript based on:

  • Scientific originality and significance of the research.

  • Methodological soundness.

  • Clarity of presentation.

  • Relevance to the journal’s scope.

  • Proper citation of references and adherence to ethical standards.

Each reviewer provides a detailed report with one of the following recommendations:

  1. Accept without revision

  2. Minor revisions required

  3. Major revisions required

  4. Reject

3. Decision and Revision

Based on the reviewers’ comments, the editorial team makes a decision and communicates it to the authors along with anonymized reviewer feedback. If revisions are required, authors are expected to submit a revised version along with a detailed response to each reviewer’s comment.

4. Final Decision

The revised manuscript may be sent back to the same reviewers for re-evaluation. Once all concerns are adequately addressed, the Editor-in-Chief makes the final decision regarding publication.

Average Timeline

The average time from initial submission to the first decision is 4 to 6 weeks, and from acceptance to publication is typically 2 to 6 weeks.

IJMI is committed to a fair, timely, and transparent review process that upholds the principles of academic excellence and ethical publishing.